The Patent Finder

Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same

Tolmar, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 12/758,770, filed Apr 12, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,778,916Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
In force
 · High confidence
Tolmar, Inc.In force
High confidence
US 10,543,219Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
In force
 · High confidence
Tolmar, Inc.In force
High confidence
US 10,617,696Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
In force
 · High confidence
Tolmar, Inc.In force
High confidence
US 11,179,403Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
In force
 · High confidence
Tolmar, Inc.In force
High confidence
US 11,426,416Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
In force
 · High confidence
Tolmar, Inc.In force
High confidence
US 8,492,369Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
In force
 · High confidence
Tolmar, Inc.In force
High confidence
US 12,778,967Methods of Treating Testosterone Deficiency
In force
 · Medium confidence
Tolmar, Inc.In force
Medium confidence
US 9,408,965Method and System for Handling and Transporting Syringes
Lapsed Aug 9, 2024 on the fee record
Ended Aug 9, 2024 · High confidence
Tolmar, Inc.Lapsed Aug 9, 2024 on the fee recordEnded Aug 9, 2024
High confidence
Application 14/216,240Methods of Treating Testosterone Deficiency
Abandoned
Abandoned Jul 17, 2017
Tolmar, Inc.AbandonedAbandoned Jul 17, 2017
Application 14/290,540Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Abandoned
Abandoned Dec 23, 2016
Tolmar, Inc.AbandonedAbandoned Dec 23, 2016
11 more patents in this group · Pro
10 of 21 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 21, including 1 expired.
Upgrade to Pro
7 of these are in force and held by Tolmar, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited